Establishment and validation of the determination method for the related substances in carbetocin injection
-
摘要:
建立一种HPLC分析方法用于卡贝缩宫素注射液中有关物质的测定。采用Waters Xbridge C18色谱柱(150 mm×3 mm,3.5 μm),0.30 mg/mL乙酸铵-19%乙腈水溶液为流动相A,流动相A-乙腈(1∶1)为流动相B,检测波长为220 nm,在60 ℃的柱温下,以0.8 mL/min的流速进行梯度洗脱。对该方法的系统适用性、专属性、线性及范围、准确度等进行了验证,结果表明卡贝缩宫素注射液的9个杂质在各自浓度范围内与峰面积呈现良好的线性关系(R2>0.999),该方法的精密度良好(RSD<5%)。本法适用于同时检测卡贝缩宫素注射液中药物及其9个杂质,可为该制剂的质量控制提供理论依据。
Abstract:An HPLC analytical method was developed to determine the related substances in carbetocin injection. The method was performed on a Waters Xbridge C18 column (150 mm×3 mm, 3.5 μm) with 0.30 mg/mL ammonium acetate-19% acetonitrile aqueous solution as mobile phase A and mobile phase A-acetonitrile (1∶1) as mobile phase B. The detection wavelength was 220 nm. Gradient elution was performed at the flow rate of 0.8 mL/min and the column temperature of 60℃. The method was validated for system applicability, specificity, linearity and range, accuracy, with the results that the 9 impurities of carbetocin injection showed good linearity (R²>0.999) with peak area in their respective concentration range, and that the method had good precision (RSD<5%). This method is suitable for the simultaneous determination of carbetocin and its 9 impurities in carbetocin injection and can provide a theoretical basis for the quality control of the carbetocin injection.
-
-
Table 1 Results of degradation study
Test Condition Assay of API/% Recovery/% Acid 10 mol/L HCl for 2 h at 40℃ 91.97 100.23 Base 5 mol/L NaOH for 5 min(r.t.) 93.23 99.61 Oxidation 10% H2O2 for 20 min(r.t.) 90.03 99.23 Light ( 5000 ±500) lx for 9 d at 25℃99.52 102.73 Heat 60℃ for 9 d 99.02 102.81 Table 2 Results of linearity test
Compd. Regression equation of linearity R2 Linear range/(μg/mL) Imp1 y= 46213 x+15.3420.9999 0.0338 –1.6921 Imp2 y= 44862 x–78.5240.9999 0.0145 –0.7229 Imp3 y= 46632 x–1.7240.9999 0.0172 –0.8613 Imp4 y= 44852 x–117.090.9999 0.0349 –1.7455 Imp5 y= 46795 x+84.1660.9999 0.0146 –0.7290 Imp6 y= 47865 x–150.30.9999 0.0143 –0.7158 Imp7 y= 44998 x–206.240.9997 0.0148 –0.7392 Imp8 y= 54607 x–108.380.9999 0.0150 –0.7503 Imp9 y= 39031 x+14.8740.9999 0.1014 –0.7603 -
[1] Borovac-Pinheiro A, Pacagnella RC, Cecatti JG, et al. Postpartum hemorrhage: new insights for definition and diagnosis[J]. Am J Obstet Gynecol, 2018, 219(2): 162-168. doi: 10.1016/j.ajog.2018.04.013
[2] Stämpfli D, Dommrich R, Orbach-Zinger S, et al. An explorative analysis of pharmacovigilance data of oxytocin and its analogue carbetocin, with a focus on haemodynamic adverse effects[J]. Int J Clin Pharm, 2023, 45(4): 922-928. doi: 10.1007/s11096-023-01587-9
[3] Liu CY, Tan XY, Zhu DM. The clinical application analysis of carbetoxine in the prevention of bleeding after cesarean section[J]. Heilongjiang Med J(黑龙江医学), 2023, 47(07): 792-794. [4] Yan JY. The Effect of carbetocin and carboprost tromethamine in the treatment of postpartum hemorrhage due to uterine contraction and their influence on the lactation function of the parturient[J]. Med Inf (医学信息), 2020, 33(21): 146-148. [5] Zhang HH. Prescription process development and quality research of carbetocin injection(卡贝缩宫素注射液处方工艺开发及质量研究)[D]. Nanjing: Nanjing University, 2019. [6] Yin LN, Huang YY, Wang C, et al. Development of a novel and stability indicating RP-HPLC-UV method for simultaneous analysis of carbetocin and ten impurities in carbetocin injection products[J]. Chromatographia, 2021, 84(10): 967-978. doi: 10.1007/s10337-021-04083-2
[7] Wang SS. Application of two-dimensional liquid chromatography-mass spectrometry in related substances research of peptide drugs(二维液相色谱-质谱联用技术在多肽类药物有关物质研究中的应用)[D]. Nanjing: Nanjing University, 2021. [8] Yang L, Yang G, Deng T. Analysis on clinical application rationality for carbetocin injection[J]. J China Prescr Drug (中国处方药), 2023, 21(3): 68-71. [9] Widmer M, Piaggio G, Nguyen TMH, et al. Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth[J]. N Engl J Med, 2018, 379(8): 743-752. doi: 10.1056/NEJMoa1805489
[10] Armbruster D, Burke T, Weeks A. Heat-stable carbetocin to prevent postpartum hemorrhage[J]. N Engl J Med, 2018, 379(24): 2380-2381. doi: 10.1056/NEJMc1812692
[11] Cook JR, Saxena K, Taylor C, et al. Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India[J]. BMC Health Serv Res, 2023, 23(1): 267. doi: 10.1186/s12913-023-09263-4
[12] Sanz-Nebot V, Garcés A, Barbosa J. Investigation of crudes of synthesis of carbetocin by liquid chromatography coupled to electrospray ionization mass spectrometry[J]. J Chromatogr A, 1999, 833(2): 267-275. doi: 10.1016/S0021-9673(98)01053-X
[13] Sanz-Nebot V, Toro I, Garcés A, et al. Separation and identification of peptide mixtures in a synthesis crude of carbetocin by liquid chromatography/electrospray ionization mass spectrometry[J]. Rapid Commun Mass Spectrom, 1999, 13(23): 2341-2347. doi: 10.1002/(SICI)1097-0231(19991215)13:23<2341::AID-RCM795>3.0.CO;2-9
[14] Zhang H, Yang HX, Liang CG, et al. HPLC analysis of carbetocin and its related impurities[J]. Chin J Pharm Anal (药物分析杂志), 2007, 27(10): 1553-1555. [15] Malm M, Madsen I, Kjellström J. Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries[J]. J Pept Sci, 2018, 24(6): e3082. doi: 10.1002/psc.3082
[16] Lin SY, Jeng SL. Comparison of ion-pairing and ion-suppressing liquid chromatographic methods for the determination of pyrimethamine and ormetoprim in chicken feed[J]. J Chromatogr Sci, 2002, 40(6): 331-336. doi: 10.1093/chromsci/40.6.331
[17] Molnár I, Horváth C. Separation of amino acids and peptides on non-polar stationary phases by high-performance liquid chromatography[J]. J Chromatogr, 1977, 142: 623-640. doi: 10.1016/S0021-9673(01)92073-4
-
期刊类型引用(1)
1. 索传军,牌艳欣. 基于融合指标与作者贡献度的z指数优化研究. 情报理论与实践. 2022(05): 28-36 . 百度学术
其他类型引用(1)